Andere talen Waters Corporation London S.E.

Aandelen

0LTI

US9418481035

Vertraagde tijd London S.E. Andere beurzen 16:08:44 17-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
295,2 ^USD	+1,35%		+0,71%	-10,09%

05/06	Transcript : Waters Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 09:30 AM
29/05	Insider van Waters kocht aandelen ter waarde van $332.900, volgens een recente SEC filing	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

ÖBAG verkauft Vamed-Beteiligung an Fresenius	04/06
Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer	03/06
Waters Becomes First Liquid Chromatography Column Provider to Receive My Green Lab ACT Ecolabel Certification	03/06
Waters Insider Bought Shares Worth $332,900, According to a Recent SEC Filing	29/05
Waters Corp Insider Sold Shares Worth $1,446,560, According to a Recent SEC Filing	16/05
Waters Corporation to Present at the Jefferies 2024 Healthcare Conference	13/05
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument	08/05
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip	08/05
Waters Seeks M&A Opportunities	07/05
Waters' Q1 Non-GAAP Earnings, Net Sales Decline; Q2 Outlook Issued	07/05
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Revenue $636.8M	07/05
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Adjusted EPS $2.21	07/05
Waters: Q1 Earnings Snapshot	07/05
Waters : Q1 2024 Non-GAAP	07/05
Waters Corporation (NYSE: WAT) Reports First Quarter 2024 Financial Results	07/05
Waters Corporation Reports Earnings Results for the First Quarter Ended March 30, 2024	07/05
Waters Corporation Provides Earnings Guidance for the Second Quarter Ending June 29, 2024 and Full Year Ending December 31, 2024	07/05
Waters Corporation Accelerates the Development of Gene-Based Therapeutics with New GTxResolve Premier SEC Columns	22/04
Waters Corporation Schedules First Quarter 2024 Earnings Conference Call	11/04
Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors	09/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Waters Corporation London S.E.

Aandelen

0LTI

US9418481035

Andere talen

Filters